Hi advalorem - thanks for the info. Actually, if this year is like previous, especially 1997, June is a good time. By then, 1) most of the interest rate concerns are likely behind us and 2) summer rally should be gathering Mo.
I-net (re)evaluation has undoubtedly caused the weakening of CDO of late, since her mark-to-market investments were likely being adjusted to reflect the current state of affair. The silver lining of the tracking stock is that the S1 [does a tracking stock also require S1?] will yield the details of the venture portfolio. Like you said, there are also biotech investments. While I-net may be highly visible, my guess is that there are also more infrastructure plays as well as biotech plays. The current markdowns are the B2C and B2B plays, but look at the chip sector, it is hotter than the cooking wafers <g>. With CDO leasing the DNA machines and chip fab equipments, I am hopeful. So long as the economy is growing, CDO core business, infrastructure and services, should grow with it, if not at a much faster rate.
best, Bosco |
